abstract |
The invention relates to novel fibroblast growth factor receptor-1 polynucleotides and polypeptides, and to compositions, uses and methods thereof. Further, this invention relates to agonists and antagonists of fibroblast growth factor receptor-1 polypeptides, as well as to methods of treatment of disorders arising from altered fibroblast growth factor receptor-1 polynucleotides and polypeptides. |